Inivata and Agendia Sign Agreement for Commercialization of RaDaR® MRD Liquid Biopsy Assay in Breast Cancer Inivata and Agendia Sign Agreement for Commercialization of RaDaR® MRD Liquid Biopsy Assay in Breast Cancer Agendia granted co-exclusive distribution rights for RaDaR in North America and Europe ...

Inivata publishes positive clinical validation results and real-world utility for its InVisionFirst®-Lung liquid biopsy test  Inivata publishes positive clinical validation results and real-world utility for its  InVisionFirst®-Lung liquid biopsy test  InVisionFirst®-Lung demonstrated excellent concordance with tissue...

Inivata Receives Medicare Final Coverage Decision for InVisionFirstTM-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer Inivata Receives Medicare Final Coverage Decision for InVisionFirstTM-Lung Liquid Biopsy Test in Advanced Non-Small Cell Lung Cancer Final Coverage Supports the Use of InVisionFirst-Lung for Aiding...

Inivata Achieves Major Milestone with Draft Medicare Local Coverage Determination (LCD) for InVisionFirst™-Lung Liquid Biopsy Test Inivata Achieves Major Milestone with Draft Medicare Local Coverage Determination (LCD) for InVisionFirst™-Lung Liquid Biopsy Test Draft Coverage Supports the Use of InVisionFirst-Lung for Aiding...

Inivata Strengthens Senior Leadership Ahead of Next Stage of Company Growth Inivata Strengthens Senior Leadership Ahead of Next Stage of Company Growth Research Triangle Park, NC and Cambridge, UK, September 12, 2018 -- Inivata, a leader in liquid biopsy, today announces...